EssilorLuxottica disclosed its share capital and voting rights as of October 31, 2026, reporting 464,247,548 shares outstanding and 458,376,127 real voting rights excluding treasury shares. The company applies a 31% cap on voting rights per shareholder as per its by-laws, ensuring no single shareholder exceeds this limit. This transparency aligns with French commercial regulations and impacts shareholder influence and governance. Investors should note the voting cap when considering their stake and voting power in the company.
EssilorLuxottica's disclosure of share capital and voting rights as of October 31, 2026, provides context for readers. For those following the Consumer Cyclical sector, here is Pluang's market snapshot as of Nov 11, 2026 00:03 WIB: out of 134 priced US stocks, 33 rose and 100 fell. Notable movers include SGI at USD 62.69 with a 1-day change of -5.40%, BIRD at USD 1.28 with a 1-day change of -5.19% and 100% buy order activity, and LEN at USD 86.85 with a 1-day change of -5.16%.
As of October 31, 2026, EssilorLuxottica disclosed its total number of shares at 464,247,548 and actual voting rights at 458,376,127 after deducting treasury shares. The company enforces a 31% voting rights cap per shareholder, as outlined in its sta...
The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...
Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...
Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...
The global nucleic acid labeling market, valued at $1.7 billion in 2025, is projected to grow to $2.8 billion by 2032 at a 7% CAGR. Growth is fueled by advances in genomics, molecular diagnostics, and personalized medicine, with increasing demand for...
